{"DataElement":{"publicId":"2538826","version":"1","preferredName":"Invasive Pancreatic Carcinoma Histologic Type Name ExocrinePancreaticCarcinomaNeoplasmHistologicTypeVD","preferredDefinition":"Diagnostic subclassification of pancreatic cancer (exocrine)","longName":"2534453v1.0:2541024v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2534453","version":"1","preferredName":"Invasive Pancreatic Carcinoma Histologic Type Name","preferredDefinition":"Marked by a tendency to spread, especially into healthy surrounding tissue.:A carcinoma arising from the exocrine pancreas.  The overwhelming majority of pancreatic carcinomas are adenocarcinomas.:Refers to the type of tissue in which a tumor originated._The words or language units by which a thing is known.","longName":"2534225v1.0:2222841v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2534225","version":"1","preferredName":"Invasive Pancreatic Carcinoma Histologic Type","preferredDefinition":"Marked by a tendency to spread, especially into healthy surrounding tissue.:A carcinoma arising from the exocrine pancreas.  The overwhelming majority of pancreatic carcinomas are adenocarcinomas.:Refers to the type of tissue in which a tumor originated.","longName":"C14159:C3850:C4741","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Invasive","conceptCode":"C14159","definition":"Marked by a tendency to spread, especially into healthy surrounding tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Pancreatic Carcinoma","conceptCode":"C3850","definition":"A carcinoma arising from the exocrine pancreas. The overwhelming majority of pancreatic carcinomas are adenocarcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm by Morphology","conceptCode":"C4741","definition":"A classification system grouping neoplasms according to their cellular characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"21204440-78E3-45AD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-31","endDate":null,"createdBy":"UMLLOADER_CAE","dateCreated":"2006-10-31","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2222841","version":"1","preferredName":"Name","preferredDefinition":"The words or language units by which a thing is known.","longName":"C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F6211245-8062-4DD9-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-02","endDate":null,"createdBy":"UMLLOADER_EVS","dateCreated":"2005-05-02","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2222502","version":"1","preferredName":"UML DEFAULT CD","preferredDefinition":"Default Conceptual Domain for UML Loader","longName":"UML DEFAULT CD","context":"caCORE","contextVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5E53F3B-47A4-52D1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-04-29","modifiedBy":"DWARZEL","dateModified":"2021-04-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2120685B-27A1-5EED-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-31","endDate":null,"createdBy":"UMLLOADER_CAE","dateCreated":"2006-10-31","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Permission to Release DEC granted by primary curator in 8/2008","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2541024","version":"1","preferredName":"ExocrinePancreaticCarcinomaNeoplasmHistologicTypeVD","preferredDefinition":"Permissible values for diagnostic subclassification of pancreatic cancer (exocrine)","longName":"2541024v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Pancreatic Ductal Adenocarcinoma","valueDescription":"Pancreatic Ductal Adenocarcinoma","ValueMeaning":{"publicId":"2581788","version":"1","preferredName":"Pancreatic Ductal Adenocarcinoma","longName":"2581788","preferredDefinition":"A carcinoma occurring almost exclusively in adults that probably arises from the pancreatic duct epithelium.  Most pancreatic carcinomas are ductal adenocarcinomas of which about two-thirds involve the head, with the remainder in the body and tail of the pancreas.  The patients are usually over 50 years of age.  Pain, jaundice, and loss of weight are the most common manifestations.  Ductal adenocarcinomas usually grow rapidly and are discovered after they have already spread beyond the pancreas.  Grossly, ductal adenocarcinomas are firm and poorly defined masses.  Microscopically, most ductal adenocarcinomas are characterized by well-developed glandular structures embedded in a desmoplastic stroma.  Ductal adenocarcinomas are fatal in the vast majority of cases (WHO 2000). --2002","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Ductal Adenocarcinoma","conceptCode":"C9120","definition":"An infiltrating adenocarcinoma that arises from the epithelial cells of the pancreas.  It affects males more often than females and the patients are usually over 50 years of age.  Microscopically it is characterized by the presence of glandular (ductal) differentiation and desmoplastic stroma formation.  Signs and symptoms include pain, loss of weight, and jaundice.  It grows rapidly and is usually detected after it has metastasized to other anatomic sites.  The prognosis is usually poor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0C89-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-10","endDate":null,"createdBy":"SCHMANDL","dateCreated":"2006-11-10","modifiedBy":"ONEDATA","dateModified":"2006-11-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21EB8750-7ACC-557C-E044-0003BA3F9857","beginDate":"2006-11-10","endDate":null,"createdBy":"SCHMANDL","dateCreated":"2006-11-10","modifiedBy":"SCHMANDL","dateModified":"2006-11-10","deletedIndicator":"No"},{"value":"Pancreatic Mucinous Noncystic Carcinoma","valueDescription":"Pancreatic Mucinous Noncystic Carcinoma","ValueMeaning":{"publicId":"2581789","version":"1","preferredName":"Pancreatic Mucinous Noncystic Carcinoma","longName":"2581789","preferredDefinition":"A pancreatic adenocarcinoma, clinicopathologically distinct from conventional pancreatic ductal adenocarcinomas, with a relatively indolent behavior (5-year survival of 55%).  It often arises in association with intraductal pancreatic mucinous neoplasms. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Colloid Carcinoma","conceptCode":"C37214","definition":"An infiltrating pancreatic ductal adenocarcinoma, characterized by the presence of malignant cells floating in pools of mucin.  It has a more favorable prognosis than the conventional infiltrating ductal adenocarcinoma.  It often arises in association with intraductal pancreatic mucinous neoplasms and in some cases it may result in the development of pseudomyxoma peritonei.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0C8A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-10","endDate":null,"createdBy":"SCHMANDL","dateCreated":"2006-11-10","modifiedBy":"ONEDATA","dateModified":"2006-11-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21EB8750-7AE4-557C-E044-0003BA3F9857","beginDate":"2006-11-10","endDate":null,"createdBy":"SCHMANDL","dateCreated":"2006-11-10","modifiedBy":"SCHMANDL","dateModified":"2006-11-10","deletedIndicator":"No"},{"value":"Signet Ring Cell Carcinoma","valueDescription":"SIGNET RING CELL CARCINOMA","ValueMeaning":{"publicId":"2560049","version":"1","preferredName":"SIGNET RING CELL CARCINOMA","longName":"2560049v1.00","preferredDefinition":"A usually aggressive, poorly differentiated invasive adenocarcinoma characterized by the presence of malignant glandular cells in which the nucleus is pressed to one side by the presence of intracytoplasmic mucus. It may arise from the stomach, small and large intestine, ampulla of Vater, appendix, gallbladder, pancreas, lung, bladder, breast, and prostate gland.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Signet Ring Cell Carcinoma","conceptCode":"C3774","definition":"A usually aggressive, poorly differentiated invasive adenocarcinoma characterized by the presence of malignant glandular cells in which the nucleus is pressed to one side by the presence of intracytoplasmic mucus. It may arise from the stomach, small and large intestine, ampulla of Vater, appendix, gallbladder, pancreas, lung, bladder, breast, and prostate gland.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B79E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"KUMMEROA","dateModified":"2023-08-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21EB8750-7AF0-557C-E044-0003BA3F9857","beginDate":"2006-11-10","endDate":null,"createdBy":"SCHMANDL","dateCreated":"2006-11-10","modifiedBy":"SCHMANDL","dateModified":"2006-11-10","deletedIndicator":"No"},{"value":"Adenosquamous Carcinoma","valueDescription":"ADENOSQUAMOUS CARCINOMA","ValueMeaning":{"publicId":"2558186","version":"1","preferredName":"ADENOSQUAMOUS CARCINOMA","longName":"2558186v1.00","preferredDefinition":"An invasive carcinoma composed of malignant glandular cells and malignant squamous cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenosquamous Carcinoma","conceptCode":"C3727","definition":"An invasive carcinoma composed of malignant glandular cells and malignant squamous cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B057-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"KUMMEROA","dateModified":"2023-08-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21EB8750-7B05-557C-E044-0003BA3F9857","beginDate":"2006-11-10","endDate":null,"createdBy":"SCHMANDL","dateCreated":"2006-11-10","modifiedBy":"SCHMANDL","dateModified":"2006-11-10","deletedIndicator":"No"},{"value":"Anaplastic Carcinoma","valueDescription":"Anaplastic Carcinoma","ValueMeaning":{"publicId":"2581790","version":"1","preferredName":"Anaplastic Carcinoma","longName":"2581790v1.00","preferredDefinition":"A usually aggressive malignant epithelial neoplasm composed of atypical cells which do not display evidence of glandular, squamous, or transitional cell differentiation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Undifferentiated Carcinoma","conceptCode":"C3692","definition":"A usually aggressive malignant epithelial neoplasm composed of atypical cells which do not display evidence of glandular, squamous, or transitional cell differentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0C8B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-10","endDate":null,"createdBy":"SCHMANDL","dateCreated":"2006-11-10","modifiedBy":"KUMMEROA","dateModified":"2023-08-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21EB8750-7B1D-557C-E044-0003BA3F9857","beginDate":"2006-11-10","endDate":null,"createdBy":"SCHMANDL","dateCreated":"2006-11-10","modifiedBy":"SCHMANDL","dateModified":"2006-11-10","deletedIndicator":"No"},{"value":"Pancreatic Osteoclast-Like Giant Cell Carcinoma","valueDescription":"Pancreatic Osteoclast-Like Giant Cell Carcinoma","ValueMeaning":{"publicId":"2581791","version":"1","preferredName":"Pancreatic Osteoclast-Like Giant Cell Carcinoma","longName":"2581791v1.00","preferredDefinition":"A rare variant of undifferentiated pancreatic carcinoma characterized by the presence of non-neoplastic osteoclast-like giant cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Undifferentiated Carcinoma with Osteoclast-Like Giant Cells","conceptCode":"C5723","definition":"A rare variant of undifferentiated pancreatic carcinoma characterized by the presence of non-neoplastic osteoclast-like giant cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0C8C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-10","endDate":null,"createdBy":"SCHMANDL","dateCreated":"2006-11-10","modifiedBy":"KUMMEROA","dateModified":"2023-08-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21EB8750-7B35-557C-E044-0003BA3F9857","beginDate":"2006-11-10","endDate":null,"createdBy":"SCHMANDL","dateCreated":"2006-11-10","modifiedBy":"SCHMANDL","dateModified":"2006-11-10","deletedIndicator":"No"},{"value":"Mixed Ductal-Endocrine Carcinoma","valueDescription":"Mixed Ductal-Endocrine Carcinoma","ValueMeaning":{"publicId":"2574561","version":"1","preferredName":"Mixed Ductal-Endocrine Carcinoma","longName":"2574561v1.00","preferredDefinition":"A carcinoma that arises from the pancreas showing a mixture of ductal and neuroendocrine malignant cells in both the primary tumor and in the metastatic sites.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Mixed Ductal-Neuroendocrine Carcinoma","conceptCode":"C6879","definition":"A carcinoma that arises from the pancreas showing a mixture of ductal and neuroendocrine malignant cells in both the primary tumor and in the metastatic sites.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F04E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-22","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-04-22","modifiedBy":"KUMMEROA","dateModified":"2023-08-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21EB8750-7B42-557C-E044-0003BA3F9857","beginDate":"2006-11-10","endDate":null,"createdBy":"SCHMANDL","dateCreated":"2006-11-10","modifiedBy":"SCHMANDL","dateModified":"2006-11-10","deletedIndicator":"No"},{"value":"Serous Cystadenocarcinoma","valueDescription":"Serous Cystadenocarcinoma","ValueMeaning":{"publicId":"2581792","version":"1","preferredName":"Serous Cystadenocarcinoma","longName":"2581792","preferredDefinition":"A malignant cystic or semicystic neoplasm. It often occurs in the ovary and usually bilaterally. The external surface is usually covered with papillary excrescences. Microscopically, the papillary patterns are predominantly epithelial overgrowths with differentiated and undifferentiated papillary serous cystadenocarcinoma cells. Psammoma bodies may be present. The tumor generally adheres to surrounding structures and produces ascites. (From Hughes, Obstetric-Gynecologic Terminology, 1972, p185)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Serous Cystadenocarcinoma","conceptCode":"C3778","definition":"A malignant serous cystic neoplasm usually involving the ovary or the pancreas. It is characterized by the presence of invasive malignant glandular epithelial cells which often form papillary structures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0C8D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-10","endDate":null,"createdBy":"SCHMANDL","dateCreated":"2006-11-10","modifiedBy":"ONEDATA","dateModified":"2006-11-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21EB8750-7B5A-557C-E044-0003BA3F9857","beginDate":"2006-11-10","endDate":null,"createdBy":"SCHMANDL","dateCreated":"2006-11-10","modifiedBy":"SCHMANDL","dateModified":"2006-11-10","deletedIndicator":"No"},{"value":"Pancreatic Invasive Mucinous Cystadenocarcinoma","valueDescription":"Pancreatic Invasive Mucinous Cystadenocarcinoma","ValueMeaning":{"publicId":"2581793","version":"1","preferredName":"Pancreatic Invasive Mucinous Cystadenocarcinoma","longName":"2581793v1.00","preferredDefinition":"A cystic epithelial neoplasm characterized by the presence of columnar mucin-producing epithelial cells, ovarian-type stroma formation, and a focal or extensive invasive carcinomatous component.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Mucinous-Cystic Neoplasm with an Associated Invasive Carcinoma","conceptCode":"C41246","definition":"A cystic epithelial neoplasm characterized by the presence of columnar mucin-producing epithelial cells, ovarian-type stroma formation, and a focal or extensive invasive carcinomatous component.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0C8E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-10","endDate":null,"createdBy":"SCHMANDL","dateCreated":"2006-11-10","modifiedBy":"KUMMEROA","dateModified":"2023-08-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21EB8750-7B72-557C-E044-0003BA3F9857","beginDate":"2006-11-10","endDate":null,"createdBy":"SCHMANDL","dateCreated":"2006-11-10","modifiedBy":"SCHMANDL","dateModified":"2006-11-10","deletedIndicator":"No"},{"value":"Pancreatic Intraductal Papillary-Mucinous Carcinoma","valueDescription":"Pancreatic Intraductal Papillary-Mucinous Carcinoma","ValueMeaning":{"publicId":"2581794","version":"1","preferredName":"Pancreatic Intraductal Papillary-Mucinous Carcinoma","longName":"2581794v1.00","preferredDefinition":"A malignant glandular neoplasm arising from the exocrine pancreas. Microscopically it is characterized by the presence of mucoid stroma formation, papillary patterns, and cystic changes. It has been associated with KRAS and Tp53 gene mutations.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Intraductal Papillary-Mucinous Carcinoma","conceptCode":"C5725","definition":"A malignant glandular neoplasm arising from the exocrine pancreas. Microscopically it is characterized by the presence of mucoid stroma formation, papillary patterns, and cystic changes. It has been associated with KRAS and Tp53 gene mutations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0C8F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-10","endDate":null,"createdBy":"SCHMANDL","dateCreated":"2006-11-10","modifiedBy":"KUMMEROA","dateModified":"2023-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21EB8750-7B8A-557C-E044-0003BA3F9857","beginDate":"2006-11-10","endDate":null,"createdBy":"SCHMANDL","dateCreated":"2006-11-10","modifiedBy":"SCHMANDL","dateModified":"2006-11-10","deletedIndicator":"No"},{"value":"Acinar Cell Carcinoma","valueDescription":"Acinar Cell Carcinoma","ValueMeaning":{"publicId":"2558157","version":"1","preferredName":"Acinar Cell Carcinoma","longName":"2558157","preferredDefinition":"A malignant glandular epithelial neoplasm consisting of secretory cells forming acinar patterns. Representative examples include the acinar cell carcinoma of the pancreas and the acinar adenocarcinoma of the prostate gland.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acinar Cell Carcinoma","conceptCode":"C3768","definition":"A malignant glandular epithelial neoplasm consisting of secretory cells forming acinar patterns. Representative examples include the acinar cell carcinoma of the pancreas and the acinar adenocarcinoma of the prostate gland.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B03A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21EB8750-7BA0-557C-E044-0003BA3F9857","beginDate":"2006-11-10","endDate":null,"createdBy":"SCHMANDL","dateCreated":"2006-11-10","modifiedBy":"SCHMANDL","dateModified":"2006-11-10","deletedIndicator":"No"},{"value":"Pancreatic Acinar Cell Cystadenocarcinoma","valueDescription":"Pancreatic Acinar Cell Cystadenocarcinoma","ValueMeaning":{"publicId":"2581795","version":"1","preferredName":"Pancreatic Acinar Cell Cystadenocarcinoma","longName":"2581795","preferredDefinition":"A cystic adenocarcinoma characterized by the presence of relatively uniform neoplastic cells which produce pancreatic enzymes and are arranged in acinar patterns. Signs and symptoms include abdominal pain, weight loss, nausea, and diarrhea. It usually has an aggressive clinical course.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Acinar Cell Cystadenocarcinoma","conceptCode":"C5727","definition":"A cystic adenocarcinoma characterized by the presence of relatively uniform neoplastic cells which produce pancreatic enzymes and are arranged in acinar patterns. Signs and symptoms include abdominal pain, weight loss, nausea, and diarrhea. It usually has an aggressive clinical course.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0C90-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-10","endDate":null,"createdBy":"SCHMANDL","dateCreated":"2006-11-10","modifiedBy":"CURTIST","dateModified":"2007-12-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21EB8750-7BB8-557C-E044-0003BA3F9857","beginDate":"2006-11-10","endDate":null,"createdBy":"SCHMANDL","dateCreated":"2006-11-10","modifiedBy":"SCHMANDL","dateModified":"2006-11-10","deletedIndicator":"No"},{"value":"Mixed Acinar-Endocrine Carcinoma","valueDescription":"Mixed Acinar-Endocrine Carcinoma","ValueMeaning":{"publicId":"2581796","version":"1","preferredName":"Mixed Acinar-Endocrine Carcinoma","longName":"2581796v1.00","preferredDefinition":"A carcinoma that arises from the pancreas showing a mixture of acinar and neuroendocrine malignant cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Mixed Acinar-Neuroendocrine Carcinoma","conceptCode":"C6878","definition":"A carcinoma that arises from the pancreas showing a mixture of acinar and neuroendocrine malignant cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0C91-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-10","endDate":null,"createdBy":"SCHMANDL","dateCreated":"2006-11-10","modifiedBy":"KUMMEROA","dateModified":"2023-08-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21EB8750-7BD0-557C-E044-0003BA3F9857","beginDate":"2006-11-10","endDate":null,"createdBy":"SCHMANDL","dateCreated":"2006-11-10","modifiedBy":"SCHMANDL","dateModified":"2006-11-10","deletedIndicator":"No"},{"value":"Carcinoma-undetermined type","valueDescription":"Carcinoma, type cannot be determined","ValueMeaning":{"publicId":"2581785","version":"1","preferredName":"Carcinoma, type cannot be determined","longName":"2581785v1.00","preferredDefinition":"An indication that a reason or result cannot be established._A malignant tumor arising from epithelial cells. Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas. Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis. Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites. Lung carcinoma, skin carcinoma, breast carcinoma, colon carcinoma, and prostate carcinoma are the most frequently seen carcinomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cannot Be Determined","conceptCode":"C179711","definition":"An indication that a reason or result cannot be established.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Carcinoma","conceptCode":"C2916","definition":"A malignant tumor arising from epithelial cells. Carcinomas that arise from glandular epithelium are called adenocarcinomas, those that arise from squamous epithelium are called squamous cell carcinomas, and those that arise from transitional epithelium are called transitional cell carcinomas. Morphologically, the malignant epithelial cells may display abnormal mitotic figures, anaplasia, and necrosis. Carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Carcinomas invade the surrounding tissues and tend to metastasize to other anatomic sites. Lung carcinoma, skin carcinoma, breast carcinoma, colon carcinoma, and prostate carcinoma are the most frequently seen carcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0C86-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-10","endDate":null,"createdBy":"SCHMANDL","dateCreated":"2006-11-10","modifiedBy":"KUMMEROA","dateModified":"2023-09-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"21EB97DF-3E17-5748-E044-0003BA3F9857","beginDate":"2006-11-10","endDate":null,"createdBy":"SCHMANDL","dateCreated":"2006-11-10","modifiedBy":"SCHMANDL","dateModified":"2006-11-10","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"21EB8749-B362-5221-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-10","endDate":null,"createdBy":"SCHMANDL","dateCreated":"2006-11-10","modifiedBy":"CURTIST","dateModified":"2012-07-17","changeDescription":"11/10/2006 lschmandt  Created per CAP checklists.  Most of the permissible values begin with 'Pancreatic', which is not the case in the CAP checklist, but those concepts already existed","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2534075","version":"1.2","longName":"caTISSUE CAE","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812223","version":"1","longName":"edu.pitt.cabig.cae.domain.pancreas","context":"NCIP"}]}],"AlternateNames":[{"name":"edu.pitt.cabig.cae.domain.pancreas.InvasiveExocrinePancreaticCarcinomaNeoplasmHistologicType.name","type":"UML Qualified Attr","context":"NCIP"},{"name":"InvasiveExocrinePancreaticCarcinomaNeoplasmHistologicType:name","type":"UML Class:UML Attr","context":"NCIP"}],"ReferenceDocuments":[{"name":"Histologic type","type":"Preferred Question Text","description":"Histologic type","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"219C176E-3A56-4DA1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-06","endDate":null,"createdBy":"UMLLOADER_CAE","dateCreated":"2006-11-06","modifiedBy":"REEVESD","dateModified":"2009-07-16","changeDescription":"Permission to Release CDE granted by primary curator, Linda Schmandt, in 8/2008","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}